Shattered Conception Podcast: Episode 39. The Placenta and What It Tells Us with Harvey Kliman, M.D., Ph.D.
My guest on Episode 39 of Shattered Conception is Dr. Harvey Kliman who has, in addition to an M.D., holds a Ph.D. in cellular biochemistry from the University of Chicago. He is currently a Research Scientist in the Department of Obstetrics and Gynecology at Yale University School of Medicine and the Director of the Reproductive and Placental Research Unit with a special interest in infertility, pregnancy complications, pregnancy loss(es) and stillbirth.Source: Shattered Conception
Stillbirth Matters Podcast: The Placenta and What It Tells Us
Our podcast guest is Dr. Harvey Kliman, MD, PhD. Listen as Chris Duffy visits with him about his research of the placenta and pregnancy outcomes. Harvey Kliman, MD, PhD, is a Research Scientist in the Department of Obstetrics, Gynecology & Reproductive Sciences and the Director of the Reproductive and Placental Research Unit at Yale. His clinical interests include infertility, implantation, recurrent pregnancy loss, endometrial receptivity testing, and placental pathology. He both does testing for impaired implantation and pregnancy loss, and sees patients.Source: Star Legacy Foundation
Hope for women with recurring pregnancy losses
For some, every pregnancy ends in a loss within six weeks. “These particular patients always have losses and they are not infertile. They get pregnant easily but they always have these losses,” says Dr. Harvey Kliman, director of the Reproductive and Placental Research Unit in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine.Source: WTNH
Progesterone may be key to preventing recurrent miscarriage
For women who suffer multiple pregnancy losses in the first four to six weeks of gestation, the hormone progesterone could offer hope for a successful birth, according to a new study by Yale School of Medicine researchers and their colleagues at University of Illinois at Chicago.
WURD Podcast: Information Is The Best Medicine
Dr. Harvey J. Kliman, Research Scientist at the Yale School of Medicine, joined the program to talk about Autism and the Placenta. Some recent research raises the possibility that analyzing the placenta after birth may provide clues to a child’s risk for developing autism.Source: WURD Radio
New Yale ResearchKit app aims to prevent pregnancy loss
One of the greatest joys for parents is the birth of their child — and one of the greatest tragedies is the loss of that child. Now, Yale physician scientist Dr. Harvey J. Kliman, has developed an iPhone app that helps women contribute to research that aims to decrease the chance of pregnancy loss due to an undersized placenta, the fetal organ that provides nourishment to the fetus.
Autism Treatment For Under-Threes Is Key, But Diagnosis Is Tough
Most children with autism are well past their fourth birthday by the time they're diagnosed with the condition, according to new government data. Their parents and teachers may have raised red flags earlier, but it takes months or years to confirm suspicions with a formal diagnosis. And therapy rarely starts without one. "The school wouldn't do anything for us until we had a diagnosis," said Kimberly Vincent, of Wallingford, whose daughter Rebekah was diagnosed at age 6.Source: The Hartford Courant
Early Childhood Autism Treatment Is Key, But Diagnosis Is Difficult
Most children with autism are well past their fourth birthday by the time they’re diagnosed with the condition, according to new government data. Although the average age of diagnosis is nearly four-and-a-half, diagnoses can reliably be made around age two. Their parents and teachers may have raised red flags earlier, but it takes months or years to confirm suspicions with a formal diagnosis. And therapy rarely starts without one.Source: WNPR
Experts: Autism treatment for kids under 3 is key, but diagnosis tough
Most children with autism are well past their fourth birthday by the time they’re diagnosed with the condition, according to new government data. Their parents and teachers may have raised red flags earlier, but it takes months or years to confirm suspicions with a formal diagnosis. And therapy rarely starts without one.Source: New Haven Register
Autism Screening at Birth: New research identifies an early biomarker in the placenta of at-risk babies.
Harvey Kliman, MD, PhD, never planned on developing the first and only test that diagnoses autism risk at birth. "What I discovered was totally by accident," the research scientist in obstetrics, gynecology, and reproductive sciences at Yale School of Medicine, revealed. Dr. Kliman, lead author of a new study published in the journal Biological Psychiatry, examined placentas and found that abnormal folds (called trophoblast inclusions) could predict whether children had a higher risk of autSource: Advance Healthcare Network
Genetic anomalies account for majority of miscarriages
A substantial majority of miscarriages appear to be caused by genetic abnormalities rather than the usual suspects of thrombophilias, antiphospholipid syndromes, immunologic problems, or other maternal factors, study results suggest.Source: Ob.Gyn. News
Placentas provide clues about autism risk at birth, study says
Researchers believe they have come up with a way to tell whether a newborn infant has a higher-than-normal risk of developing autism -- by looking for abnormalities in the placenta shortly after birth. The abnormalities in question are called trophoblast inclusions, or TIs.Source: Los Angeles Times
Autism May Be Linked to Placenta Abnormalities
It's much too early to say that an examination of the placenta could be used as a definitive test for autism at birth, said study researcher Dr. Harvey Kliman, director of Reproductive and Placental Research at the Yale University School of Medicine. Autism spectrum disorders are typically diagnosed when children are ages 3 or 4, or even older.Source: MyHeatlhNewsDaily
Autism risk spotted at birth in abnormal placentas
Yale researchers have figured out how to measure an infant’s risk of developing autism by looking for abnormalities in his/her placenta at birth, allowing for earlier diagnosis and treatment for the developmental disorder. The findings are reported in the April 25 online issue of Biological Psychiatry.